Ticker: KPTI

Company: Karyopharm Therapeutics Inc.

Person: Stuart Poulton, officer

Transaction date: July 28, 2026

Reporting date: July 30, 2026

Average share price: 7.1

Sold 189.0 shares for 1341.9